JP2005015461A5 - - Google Patents

Download PDF

Info

Publication number
JP2005015461A5
JP2005015461A5 JP2003376833A JP2003376833A JP2005015461A5 JP 2005015461 A5 JP2005015461 A5 JP 2005015461A5 JP 2003376833 A JP2003376833 A JP 2003376833A JP 2003376833 A JP2003376833 A JP 2003376833A JP 2005015461 A5 JP2005015461 A5 JP 2005015461A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
substituent
group
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003376833A
Other languages
English (en)
Japanese (ja)
Other versions
JP4594611B2 (ja
JP2005015461A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003376833A priority Critical patent/JP4594611B2/ja
Priority claimed from JP2003376833A external-priority patent/JP4594611B2/ja
Publication of JP2005015461A publication Critical patent/JP2005015461A/ja
Publication of JP2005015461A5 publication Critical patent/JP2005015461A5/ja
Application granted granted Critical
Publication of JP4594611B2 publication Critical patent/JP4594611B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003376833A 2002-11-08 2003-11-06 受容体機能調節剤 Expired - Fee Related JP4594611B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003376833A JP4594611B2 (ja) 2002-11-08 2003-11-06 受容体機能調節剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002324632 2002-11-08
JP2003016889 2003-01-27
JP2003153986 2003-05-30
JP2003376833A JP4594611B2 (ja) 2002-11-08 2003-11-06 受容体機能調節剤

Publications (3)

Publication Number Publication Date
JP2005015461A JP2005015461A (ja) 2005-01-20
JP2005015461A5 true JP2005015461A5 (cg-RX-API-DMAC10.html) 2006-12-14
JP4594611B2 JP4594611B2 (ja) 2010-12-08

Family

ID=34199130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003376833A Expired - Fee Related JP4594611B2 (ja) 2002-11-08 2003-11-06 受容体機能調節剤

Country Status (1)

Country Link
JP (1) JP4594611B2 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004268455B2 (en) * 2003-08-29 2009-12-17 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof
WO2005063725A1 (ja) * 2003-12-26 2005-07-14 Takeda Pharmaceutical Company Limited フェニルプロパン酸誘導体
EP1737809B1 (en) * 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
JP4859665B2 (ja) * 2004-03-30 2012-01-25 武田薬品工業株式会社 アルコキシフェニルプロパン酸誘導体
WO2006080406A1 (ja) * 2005-01-28 2006-08-03 Taisho Pharmaceutical Co., Ltd. 三環性化合物
TW200815377A (en) 2006-04-24 2008-04-01 Astellas Pharma Inc Oxadiazolidinedione compound
TW200838526A (en) * 2006-12-01 2008-10-01 Astellas Pharma Inc Carboxylic acid derivatives
ES2446419T3 (es) * 2007-04-16 2014-03-07 Amgen, Inc Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos
EP2151236A4 (en) * 2007-04-26 2013-01-16 Japan Science & Tech Agency G-PROTEIN-CONJUGATED RECEPTOR AGONIST
FR2917084B1 (fr) * 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl propanoique activateurs des recpteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
JP5591706B2 (ja) * 2007-10-10 2014-09-17 アムジエン・インコーポレーテツド 置換ビフェニルgpr40調節因子
TWI421070B (zh) * 2007-10-26 2014-01-01 Japan Tobacco Inc 螺化合物及其醫藥用途
AU2008319418B2 (en) * 2007-10-29 2013-08-15 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2010085811A2 (en) * 2009-01-26 2010-07-29 Taipei Medical University Use of pterosin compounds for treating diabetes and obesity
PH12012501456A1 (en) 2009-12-25 2012-10-29 Mochida Pharm Co Ltd Novel 3-hydroxy -5- arylisothiazole derivative
EP2646425B1 (en) * 2010-12-01 2015-06-10 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids useful for the treatment of metabolic syndrome
AR085990A1 (es) 2011-04-27 2013-11-13 Mochida Pharm Co Ltd Derivados de 1-oxido de 3-hidroxiisotiazol utiles en el tratamiento de la diabetes y composiciones farmaceuticas que los contienen
JPWO2012147516A1 (ja) * 2011-04-28 2014-07-28 持田製薬株式会社 環状アミド誘導体
WO2013122029A1 (ja) * 2012-02-13 2013-08-22 武田薬品工業株式会社 芳香環化合物
US8642585B2 (en) * 2012-03-26 2014-02-04 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids
US8809376B2 (en) * 2012-04-30 2014-08-19 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids
JP6314335B2 (ja) * 2013-02-06 2018-04-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新しいインダニルオキシジヒドロベンゾフラニル酢酸
JP6333355B2 (ja) * 2013-03-14 2018-05-30 ヤンセン ファーマシューティカ エヌ.ベー. Gpr120のアゴニストとして有用な二環式ピロール誘導体
EP3114123B1 (en) * 2014-03-07 2018-04-25 Janssen Pharmaceutica NV Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes
JP6699011B2 (ja) * 2014-07-04 2020-05-27 国立大学法人 東京大学 脂肪酸サロゲートを含むリゾホスファチジルセリン誘導体
US10882833B2 (en) * 2016-05-23 2021-01-05 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof
WO2018107158A1 (en) * 2016-12-09 2018-06-14 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase
KR102007633B1 (ko) * 2016-12-15 2019-08-06 일동제약(주) 신규 페닐 프로피온 산 유도체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE433964T1 (de) * 2000-12-28 2009-07-15 Takeda Pharmaceutical Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
MXPA04001253A (es) * 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
AU2003211384B2 (en) * 2002-02-21 2008-12-11 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivative and use thereof

Similar Documents

Publication Publication Date Title
US4826990A (en) 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
Flynn et al. Styrylpyrazoles, styrylisoxazoles, and styrylisothiazoles. Novel 5-lipoxygenase and cyclooxygenase inhibitors
US8367843B2 (en) Phenol derivative
US5120758A (en) Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
US5103014A (en) Certain 3,3'-[[[(2-phenyl-4-thiazolyl)methoxy]phenyl]methylene]dithiobis-propanoic acid derivatives
CA2323707C (fr) Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4772703A (en) 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
CZ397598A3 (cs) Derivát 5-fenoxyalkyl-2,4-thiazolidindionu, způsob jeho přípravy, meziprodukty pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
HU196592B (en) Process for producing new benzene derivatives and pharmaceutics comprising them as active ingredient
US4895953A (en) 2-Aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
SK278578B6 (en) Preparation method of benzcycloalkenyldihydroxyalkanoic acids derivatives
US6133279A (en) Therapeutic agents for renal diseases and organ preservatives
US4942236A (en) 2-aryl substituted pyridyl-containing phenyl sulfonamido compounds as antiallergic and antiinflammatory agents
EP0226342A1 (en) 5-Phenyl-2-oxazole derivatives as anti-inflammatory/antiallergic agents
US20070161697A1 (en) Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
EP0263229A1 (en) Phenol derivatives, their preparation and the use thereof
US4483861A (en) Antihypertensive sulfur-containing compounds
CA2563000C (en) Indene derivatives and process for the preparation thereof
US5232941A (en) Caffeic acid derivatives and pharmaceutical compositions containing the same
Aizawa et al. Studies on hindered phenols and analogs. 2. 1, 3-Benzoxathioles having SRS-A inhibiting activity
US4550172A (en) Novel heterocyclic compounds as antiallergic agents
JP4348300B2 (ja) 1,2,4−トリアゾール誘導体、その製造方法、およびそれを含む薬学的組成物
WO1998042680A1 (en) Novel anilide compounds and drugs containing the same
US5155130A (en) Certain benzopyran and benzothiopyran derivatives
JP4532283B2 (ja) 1,2,4−トリアゾール誘導体、その調製のための過程およびそれらを含む薬学的組成物